Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk. 2009

Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, and First Department of Surgery, Elena Venizelou Hospital, Athens, Greece. pdlagiou@med.uoa.gr

Estrogens play a central role in the etiology of breast cancer, and results from observational studies and randomized trials have also implicated progestins. The effects of these hormones in the mammary tissue are exerted through binding with specific receptor proteins in the cell nucleus. It has been proposed that higher estrogen receptor alpha expression in the normal breast epithelium may increase breast cancer risk. In a study in Greece, we determined estrogen alpha and progesterone receptor expression in normal mammary tissue adjacent to the pathological tissue from 267 women with breast cancer and 299 women with benign breast disease. Mouse monoclonal antibodies specific for estrogen receptor alpha and progesterone receptor were applied. The H-index, which incorporates frequency and intensity of staining of the cells, and can range from 0 to 300, was deemed positive when it exceeded 9. Among premenopausal women, there was no evidence for an association with breast cancer risk for expression of either type of receptors. Among postmenopausal women, breast cancer risk was inversely associated with expression of both estrogen alpha (odds ratio (OR)=0.39; p=0.015) and progesterone (OR=0.40; p=0.008) receptors. The hypothesis that overexpression of estrogen receptors alpha or progesterone receptors in normal breast epithelium may increase the risk of breast cancer was not supported by our data. Instead, we found evidence that overexpression of these receptors may be associated with reduced risk for breast cancer in line with the well-known association of expression of these receptors in the malignant tissue and better breast cancer prognosis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001941 Breast Diseases Pathological processes of the BREAST. Endocrine Breast Diseases,Breast Disease,Breast Disease, Endocrine,Breast Diseases, Endocrine,Disease, Breast,Disease, Endocrine Breast,Diseases, Breast,Diseases, Endocrine Breast,Endocrine Breast Disease
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
January 2007, In vivo (Athens, Greece),
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
January 2016, NPJ breast cancer,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
January 2017, NPJ breast cancer,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
January 1998, Journal of the National Cancer Institute,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
December 2002, International journal of cancer,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
April 2000, American journal of epidemiology,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
January 2007, The Journal of steroid biochemistry and molecular biology,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
May 2010, Applied immunohistochemistry & molecular morphology : AIMM,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
June 2009, Endocrine,
Pagona Lagiou, and Christina Georgila, and Evangelia Samoli, and Areti Lagiou, and Pantelina Zourna, and Ploumitsa Minaki, and Dorothy Vassilarou, and Ioannis Papadiamandis, and Constantinos Sfikas, and Victoria Kalapothaki, and Constantine E Sekeris, and Dimitrios Trichopoulos
January 1998, Journal of the National Cancer Institute,
Copied contents to your clipboard!